From Deathbed to Hope:
Stage 4 Lung Cancer Patientβs Plea to the FDA
Meet Allie, and Stacy Martin at the Soon-Shiong Clinic.
Stacey has stage 4 lung cancer. She was on her deathbed.
By the grace of God she got into the clinic and is beginning ANKTIVA therapy.
Her special plea to the FDA is simple: cut the red tape. Allow access for all cancer patients. Lower the standard-of-care requirements. This treatment should be available nationwide.
The have to fly from Florida to California for Treatment.
Thatβs the message. Share it. @FDA@DrPatrick@bullishbruk
@NancyMace A truly beautiful woman. I understand is difficult to predict how someone would respond in such circumstances. I like to think that my wife or I would sacrifice the same as Emma did. I hope we or anyone else don't have to go through this.
Our @ImmunityBio team is having great reception at World Conference Lung Cancer (WCLC26) in Seoul Korea discussing ReQ201A-NSCLC (Phase 3).
The world is waking up to the fact that ALC (absolute lymphocyte count) and Natural Killer (NK) cells matter to prolong life. The conclusion from the Chudzik abstract is consistent with what we saw in QUILT-3.055
https://t.co/WOe5Chw2sW
Abstract: P3.175: Peripheral Blood Immunophenotyping Reveals Patterns of Short and Durable Immunotherapy Response in NSCLC. Robert Chudzik et al., 2026
@LoriMills4CA42 The FDA is evil. No person with cancer or seriously threatening disease should wait for their treatment to fail to have the chance of better outcome. More important, when the side effects are proven to be minimal risk. @FDA
@SaltyGoat17 Many people's moral compass is completely broken. Eliminating Journalism protecting one side should fix a big chunk of the problem. Remove government funding.
@ThomasSowell No. AI with no physical product is weak imo. It can be easily outpaced by competitors and @grok is showing better results with 4.7 coming